Does Lipitor Offer Income-Based Rebates?
No, Lipitor (atorvastatin) does not offer rebates directly tied to patient income. The drug's manufacturer, Pfizer, provides copay savings cards and patient assistance programs, but these focus on insurance status, medication affordability, or specific medical needs rather than income levels.[1]
How Pfizer's Copay Savings Card Works for Lipitor
Eligible commercially insured patients pay as little as $4 per 30-day prescription (up to 12 fills yearly), regardless of income. No income verification required—just a valid prescription and commercial insurance. Uninsured patients typically don't qualify.[1][2]
Pfizer Patient Assistance Programs
Pfizer's Pfizer RxPathways offers free Lipitor for uninsured or underinsured U.S. patients meeting these criteria:
- Household income up to 400-700% of the federal poverty level (varies by program and family size).
- U.S. residency and lack of government insurance like Medicare.
This is direct medication provision, not rebates, and covers eligible Pfizer drugs including Lipitor. Apply online or by phone.[3]
Income Thresholds for Free Lipitor via RxPathways
| Family Size | Max Annual Income (400% FPL) | Max for Some Programs (up to 700% FPL) |
|-------------|------------------------------|---------------------------------------|
| 1 | $58,320 | $102,060 |
| 2 | $78,880 | $138,140 |
| 4 | $120,000 | $210,000 |
Figures based on 2024 federal poverty levels; check Pfizer site for updates.[3]
Alternatives if You Don't Qualify
- GoodRx or SingleCare: Discount cards cut Lipitor's cash price from ~$150-300/month to $10-30 at pharmacies, no income check.[4]
- NeedyMeds or Partnership for Prescription Assistance: Connect to broader income-based aid for statins.
- Generic atorvastatin: Available since 2011 patent expiry; often $5-15/month via most pharmacies.[5]
No active Lipitor patents remain per DrugPatentWatch.com.[5]
When Lipitor Went Generic and Price Impact
Lipitor's main patent expired November 2011, leading to generics that dropped prices 80-90%. Biosimilars aren't relevant as it's a small molecule.[5]
Sources
[1]: Pfizer Lipitor Savings Card
[2]: Pfizer Patient Assistance Overview
[3]: Pfizer RxPathways
[4]: GoodRx Atorvastatin Prices
[5]: DrugPatentWatch.com - Lipitor Patents